North America Clinical Laboratory Test Market Overview
Clinical laboratory testing has emerged as the most growing segment of healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood test, anatomical pathological testing, molecular, immunological, drug testing and other tests for disease diagnosis and treatment.
According to a recent study report published by the Market Research Future analysts, the North America Clinical Laboratory Test Market size is growing at a steady pace; where the growth is mainly due to increasing prevalence of chronic diseases, increased patient population, increase in volume of in-vitro diagnostic tests, current reimbursement scenario, and increasing patient awareness about the clinical test.
However, there are few obstacles for this market. Massive development costs for the each tests ultimately results in increased costs for the test. In 2014 According to office of inspector general, three test all of blood test accounts over $400 million each which include complete blood cell count automated test which accounts $431 million, blood test for a group of blood chemicals which accounts $453 million, blood test for thyroid‐stimulating hormone which accounts $477 million.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/2249
North America Clinical Laboratory Test Market Segmentation
The North America clinical laboratory test market size is majorly segmented on the basis of type of laboratory, type of test, and by country.
• Based on the type of laboratory, the market is segmented into hospital based laboratory, central/ independent laboratory, physician office laboratory, and others.
• Based on type of test these are classified into CBC and other routine test, anatomic pathology, molecular test, immunology test, drug test and others.
• Further on the basis of country the market is classified into U.S., Canada, and Rest of North America.
North America Clinical Laboratory Test Market Regional Analysis
US accounts for the maximum market share of North America Clinical Laboratory testing market and is expected to grow at a CAGR of 5.8% during the forecasted period. Maximum number of laboratories and clinical testing procedures are the major reason for the highest market growth of this region. Canada, is expected to be the fastest growing region with the CAGR of 6.3% during the forecasted period due to increasing cases of chronic disease and also because of new companies providing laboratory services entering Canadian market.
North America Clinical Laboratory Test Market Players
• Globus Medical, Inc. (U.S.)
• Depuy Synthes Inc. (Johnson & Johnson) (U.S.)
• Smith & Nephew plc. (UK)
• NuVasive, Inc. (U.S.)
• Stryker Corporation (U.S.)
• Integra LifeSciences Holdings Corporation (U.S.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Medtronic, plc (Ireland)
• Wright Medical Group N.V. (Netherlands)
• The Orthopedic Implant Company (U.S.)
• Aesculap Implant Systems (U.S.)
• Conmed Corporation (U.S.)
• BioTek Instruments, Inc. (U.S.)
• Arthrocare Corporation (U.S.)
among others are some key companies in the global North America Clinical Laboratory Test that are listed by MRFR for market research.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/america-clinical-labor...
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]